Hermès Made A Statement With Its Latest Results, And Ozempic Was Linked To A Lower Risk Of Alzheimer’s
The Finimize Daily Brief - Un podcast de Finimize
Catégories:
Hermès made a splashy statement with its latest results, outshining its luxury rivals, while Novo Nordisk’s popular weight-loss drug has been linked to a lowered risk of Alzheimer’s.Today’s stories:Hermès Came Out On Top With Its Latest Results, Leaving Luxury Rivals In The DustNovo Nordisk's Ozempic Drug Might Work Wonders For Mind As Well As BodyTry Finimize Premium
